News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
A clear picture of the ground reality
S.S. Datta/palliativecare.in
Nov 13, 2024, 16:25

A clear picture of the ground reality

Bishal Gyawali, Associate Professor at Queen’s University, shared an article by S.S. Datta on LinkedIn, adding:

“The best part of our paper is the quotes.

These quotes give you a clear picture of the ground reality.”

A clear picture of the ground reality

What constitutes meaningful benefit of cancer drugs in the context of LMICs? A mixed-methods study of oncologists’ perceptions on endpoints, benefit, price, and value of cancer drugs.

Authors: S.S. Datta, et al.

A clear picture of the ground reality

Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology. 

Bishal Gyawali cancer cancer drugs LMICs medical oncologist Nepal OncoDaily Oncology picture Queen’s University S.S. Datta
Special Coverage
Insight
Jan 15, 2025, 13:50
Senthil Kumar: Systemic Treatment for Advanced/Metastatic Synovial Sarcoma
Blog
Jan 15, 2025, 13:48
Rahul Banerjee: My takeaways from RedirecTT-1 for Fred Hutchinson Cancer Center journal watch
Opinion
Jan 15, 2025, 13:47
5 Articles suggested by Wafik El-Deiry
Dialogues
Jan 15, 2025, 13:46
Global Equity of Clinical Trials - Global Cancer Movement
Blog
Jan 15, 2025, 13:45
Laura Alder: Honored, thankful, and excited to be a part of the 2025 IASLC Academy
Science
Jan 15, 2025, 13:40
Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.
Blog
Jan 15, 2025, 13:35
Wafik S. El-Deiry: TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury
Blog
Jan 15, 2025, 13:33
Brian Shields: Pharma's AI Ventures - Helpful Tips for Senior Executive Leaders
Blog
Jan 15, 2025, 13:30
Francisco J. Esteva: FDA has mandated that all mammography facilities include breast density information in their reports
Career
Jan 15, 2025, 13:30
Krzysztof Ptak has been appointed as Director of the Office of Cancer Centers at the National Cancer Institute (NCI)
Blog
Jan 15, 2025, 13:27
Updates about NRG's NCORP Program - NRG Oncology
Blog
Jan 15, 2025, 13:25
Miguel Bronchud: Osteosarcoma as a remarkable example of a cancer characterized by chromothripsis